Overview The News Click Therapeutics has received FDA 510(k) clearance for Motivista (CT-155), a smartphone-based prescription digital therapeutic indicated for treating negative symptoms of schizophr...
Overview The News Flow Neuroscience has launched FL-100 in the US, giving clinicians a new at-home treatment option for adults aged 18 and older with moderate to severe major depressive disorder who a...
Healthcare is entering a new era where software is becoming an integral part of treatment. Digital Therapeutics (DTx) are evidence-based software solutions designed to prevent, manage, or treat medica...
Preventive healthcare is becoming a central focus of modern medicine, shifting the emphasis from treating illness to promoting long-term health and wellbeing. At the heart of this transformation are c...
Healthcare organisations are under increasing pressure to deliver high-quality patient care while improving operational efficiency, reducing costs, and adapting to evolving regulatory requir...
